newsfilter
← Latest News
GlobeNewswire·

Eton Pharmaceuticals Reports Third Quarter 2026 Financial Results

Record Q3 2026 product sales of $57.9 million, 158% year-over-year growth; surpassed $200 million annualized revenue run rate goal five quarters ahead of scheduleQ3 2026 fully diluted GAAP EPS of $1.06, non-GAAP fully